Nasopharynx Cancer Clinical Trial
Official title:
A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Nasopharynx
The purpose of this study is to collect outcomes information to see what effects photon/proton beam radiation has on nasopharynx cancer.
Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05483374 -
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
|
||
Active, not recruiting |
NCT03082534 -
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT03096808 -
Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 2 | |
Not yet recruiting |
NCT04004871 -
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma
|
Phase 2 | |
Recruiting |
NCT06019130 -
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
|
Phase 2 | |
Completed |
NCT03791944 -
3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma
|
N/A |